Answers are grounded in this paper and cite their sources.
A safe and scalable synthesis of 2-amino-4-(ethylsulfonyl) phenol has been established. The route commences with the alkylation of commercially available 4-chlorobenzenethiol using ethyl iodide to afford (4-chlorophenyl) (ethyl)sulfane. A key feature of this work is the implementation of a telescoped continuous-flow platform that seamlessly integrates two inherently hazardous transformations: the oxidation of the sulfide to the sulfone by NaClO₂/AcOH, followed immediately by regioselective nitration with an HNO₃/H₂SO₄ mixture to yield 1-chloro-4-(ethylsulfonyl)-2-nitrobenzene. Subsequent hydrolysis and an iron (III)-catalyzed reduction furnished the target aminophenol intermediate. Finally, condensation with 2-naphthoic acid, promoted by Eaton’s reagent, delivered the active pharmaceutical ingredient (API) ezutromid. This continuous-flow strategy effectively mitigates the safety risks associated with the oxidation and nitration steps while demonstrating robust scalability. The process reliably produces batches exceeding 100 g (with single-pass oxidation throughput reaching 140 g), maintains high selectivity throughout, and requires only straightforward aqueous workups.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: